Content about Acquisition

April 23, 2012

Par Pharmaceutical has bought rights to a generic drug for gastroesophageal reflux disease from Handa Pharmaceuticals, Par said.

April 13, 2012

The Body Shop, which was acquired by L’Oréal in 2006, is looking to revamp its 2,700 global stores to its new store concept, dubbed “Pulse,” according to published reports.

April 11, 2012

Takeda Pharmaceutical will acquire privately owned drug maker URL Pharma for $800 million, the companies said Wednesday.

April 10, 2012

Biotech manufacturer Amgen will acquire the private South San Francisco, Calif.-based drug developer Kai Pharmaceuticals for $315 million, the companies said Tuesday.

April 9, 2012

Sensible Organics, a maker of organic personal care products and one of the first beauty care companies to receive the U.S. Department of Agriculture national organic certification, has announced that it will launch its Nourish Organic Food for Healthy Skin brand at Whole Foods stores nationwide.

April 6, 2012

Par Pharmaceutical has started shipping its generic version of a drug for sleep disorders, the company said Friday.

April 3, 2012

Forest Labs has bought rights to a drug used for high blood pressure that it had marketed with a Johnson & Johnson subsidiary, thus eliminating the need to pay future royalties.

April 2, 2012

A leading provider of immune support products has become part of Schiff Nutrition.

March 30, 2012

Teva Pharmaceutical Industries has launched an authorized generic version of Cephalon's Provigil, used for conditions like shift work sleep disorder and narcolepsy, the company said Friday.

March 27, 2012

Hyperion Therapeutics has purchased rights to a drug for treating genetic metabolic disorders, the company said.

March 23, 2012

Former Walgreens' CEO Jeff Rein said profit pressure might cause Walgreens to think differently about acquisitions than it did in the past.

March 19, 2012

Walgreens might be willing to acquire Rite Aid if it can't settle an ongoing contractual dispute with one of the country's largest pharmacy benefit managers, Walgreens' former CEO said in a conference call with investors Monday.

March 6, 2012

AmerisourceBergen on Tuesday announced that it has signed a definitive agreement to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

February 22, 2012

Novartis plans to pay up to $440 million for rights to a drug for treating hepatitis C made by Enanta Pharmaceuticals, Enanta said.

February 21, 2012

A division of Pfizer is asserting that it incurred nearly $1 billion in damages related to the launch of generic versions of one of its drugs.

February 17, 2012

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams.

February 15, 2012

Kellogg's is fortifying its snacks business by purchasing Procter & Gamble's Pringles business for nearly $2.7 billion.

February 13, 2012

Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.

February 6, 2012

Mylan has completed its acquisition of two skin drugs from Valeant Pharmaceuticals, the generic drug maker said Monday.

February 2, 2012

Acosta Sales and Marketing on Wednesday announced it has completed the acquisition of Griffin Strategic Advisors and will form a new business unit called AMG Strategic Advisors.

February 1, 2012

Ever wonder how the convenient care industry blossomed into what it is today? One could say a fortune cookie.

January 26, 2012

Drug maker Amgen is acquiring a Rockville, Md.-based company developing therapies for cancer, the companies said Thursday.

January 11, 2012

PZ Cussons, a consumer products group in Europe, Asia and Africa, is expanding its beauty division with the acquisition of the Fudge hair care brand from Australia-based Sabre Group.

January 9, 2012

Bristol-Myers Squibb is buying Inhibitex for $2.5 billion, the companies said.

© 2014 Drug Store News. All Rights Reserved.